当前位置: X-MOL 学术Diabetes Res. Clin. Pract. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Long term outcomes after incident diabetic foot ulcer: Multicenter large cohort prospective study (EDI-FOCUS investigators) epidemiology of diabetic foot complications study: Epidemiology of diabetic foot complications study.
Diabetes Research and Clinical Practice ( IF 5.1 ) Pub Date : 2020-03-09 , DOI: 10.1016/j.diabres.2020.108113
Ashu Rastogi 1 , Ghanshyam Goyal 2 , Rajesh Kesavan 3 , Arun Bal 4 , Harish Kumar 4 , Mangalanadanam 4 , Priyatham Kamath 4 , Edward B Jude 5 , David G Armstrong 6 , Anil Bhansali 1
Affiliation  

AIMS This long-term prospective study evaluated limb amputation and mortality after the first neuropathic diabetic foot ulcer (DFU). METHODS A total of 2880 patients with neuropathic DFU (DFU group) and a similar number of patients of diabetes without DFU (nDFU) matched for age and diabetes duration were prospectively assessed at five referral-centers over 14 years. Pre-defined outcome was death during follow-up. Various diabetic co-morbidities and amputation were assessed as mortality predictors. RESULTS Overall, 501 (17.4%) patients in DFU group died compared to 89 (3.1%) (p < 0.01) in nDFU group during a median follow-up of 7(1-14) years. The 5- and 10-year mortality was 22% and 71% in the DFU group with a median survival of 7.72 (7.37-8.08) years compared to 3% (p < 0.01) and 5% (p < 0.01) and survival of 12.6 (10.5-12.7) years (p < 0.001) in nDFU group. 29.3% patients had limb amputations. The mortality risk was independent of glycemic control [OR 1.03 (0.80-1.32; p = 0.83)]. However, diabetes duration > 10 years [OR 1.31(1.02-1.70, p = 0.035)], nephropathy [OR 1.47 (1.04-2.09, p < 0.030)], minor 1.85 (1.40-2.44; p < 0.001) or major amputation 2.96 (2.01-4.34, p < 0.001)] predicted mortality. CONCLUSIONS Every one-in-three individual with neuropathic DFU has amputation and every sixth individual has an early demise. Prevalent nephropathy and incident amputation following DFU predicts mortality.

中文翻译:

糖尿病足溃疡事件的长期结果:多中心大型队列前瞻性研究(EDI-FOCUS研究者)糖尿病足并发症的流行病学研究:糖尿病足并发症的流行病学研究。

目的这项长期的前瞻性研究评估了首例神经性糖尿病足溃疡(DFU)后的肢体截肢和死亡率。方法前瞻性评估了14个年龄在5个转诊中心进行的2880例神经性DFU患者(DFU组)和与年龄和糖尿病持续时间相匹配的无DFU糖尿病患者(nDFU)的数量。预定义的结果是随访期间的死亡。各种糖尿病合并症和截肢被评估为死亡率预测指标。结果总体而言,在7(1-14)年的中位随访期间,DFU组的501名患者(17.4%)死亡,而nDFU组的89名(3.1%)(p <0.01)死亡。DFU组的5年和10年死亡率分别为22%和71%,中位生存期为7.72(7.37-8.08)年,而3%(p <0.01)和5%(p <0.01) 12.6(10.5-12。nDFU组为7)年(p <0.001)。29.3%的患者截肢。死亡风险与血糖控制无关[OR 1.03(0.80-1.32; p = 0.83)]。但是,糖尿病持续时间> 10年[OR 1.31(1.02-1.70,p = 0.035)],肾病[OR 1.47(1.04-2.09,p <0.030)],轻度1.85(1.40-2.44; p <0.001)或大截肢2.96(2.01-4.34,p <0.001)]预测死亡率。结论每三分之一的神经性DFU患者都会截肢,而每六分之一则患者会早逝。DFU继发的肾病和截肢可预测死亡率。p <0.030)],较小的1.85(1.40-2.44; p <0.001)或较大的截肢2.96(2.01-4.34,p <0.001)]预测死亡率。结论每三分之一的神经性DFU患者都会截肢,而每六分之一则患者会早逝。DFU继发的肾病和截肢可预测死亡率。p <0.030)],较小的1.85(1.40-2.44; p <0.001)或较大的截肢2.96(2.01-4.34,p <0.001)]预测死亡率。结论每三分之一的神经性DFU患者都会截肢,而每六分之一则患者会早逝。DFU继发的肾病和截肢可预测死亡率。
更新日期:2020-03-09
down
wechat
bug